Long-Term Efficacy and Tolerability of a Medium G' HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone.

Injectable hyaluronic acid-based fillers are commonly used for the correction of skin contour irregularities and to smooth skin depressions formed by volume loss during the aging process. These fillers are particularly efficient to restore perioral skin depressions/wrinkles or to correct topographical anomalies. The European directives require a continuous evaluation of the performance of these medical devices, particularly for CE marked products. An 18-month prospective randomized single-blind study for the efficacy and safety of ART FILLER Universal (AFU) was performed on the lips, the nasolabial folds, and the marionettes lines. The evaluations were performed on 153 subjects enrolled in this study. The efficacy, the longevity, and the safety were evaluated for the injected areas via area specific clinical scoring after a single injection with the filler and with no re-touch. We showed here that filler injection induced potent improvements of volume restoration after a single injection on all the treated areas. These beneficial properties of the filler were significant 3 weeks after injection and during the whole study period. Moreover, injections of the filler were well tolerated by the subjects. The recorded adverse events are routinely seen with HA fillers for face volume corrections, and most of these local reactions resolved within 14 days. AFU was well tolerated and showed a continuous efficacy for at least 18 months, in exploratory analyses.

Informations de copyright

© 2023 David et al.

Déclaration de conflit d'intérêts

The hyaluronic acid-based filler under investigation in this study is a product developed and commercialized by FILLMED Laboratories. Dr Ferial Fanian and Dr Karim Nadra are both employees of FILLMED Laboratories. Dr Frederic Loreto reports personal fees from Filorga, during the conduct of the study. None of the other authors declared any potential conflicts of interest with respect to the research, authorship, and publication of this article.